AA
KNSA icon

AlphaCentric Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

AlphaCentric Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,478
Closed -$287K – 253
2024
Q3 		$287K Buy
+11,478
New +$280K 0.21% 111
2023
Q4 		– Sell
-110,000
Closed -$1.91M – 266
2023
Q3 		$1.91M Hold
110,000
– – 1.08% 30
2023
Q2 		$1.55M Buy
110,000
+27,500
+33% +$368K 0.86% 43
2023
Q1 		$888K Buy
82,500
+37,500
+83% +$494K 0.61% 59
2022
Q4 		$674K Buy
45,000
+2,000
+5% +$29.1K 0.67% 55
2022
Q3 		$552K Buy
+43,000
New +$490K 0.57% 53
2021
Q3 		– Sell
-32,500
Closed -$453K – 211
2021
Q2 		$453K Buy
32,500
+13,500
+71% +$205K 0.12% 68
2021
Q1 		$352K Buy
19,000
+3,500
+23% +$71.6K 0.12% 66
2020
Q4 		$274K Buy
15,500
+11,500
+288% +$202K 0.11% 46
2020
Q3 		$61K Buy
+4,000
New +$75.1K 0.03% 93

Other funds holding KNSA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return